Risk factors for developing upper limb cellulitis after breast cancer treatment.


Journal

Lymphology
ISSN: 2522-7963
Titre abrégé: Lymphology
Pays: United States
ID NLM: 0155112

Informations de publication

Date de publication:
2022
Historique:
entrez: 28 9 2022
pubmed: 29 9 2022
medline: 1 10 2022
Statut: ppublish

Résumé

Cellulitis is one of the most important troubling complications of breast cancer treatment. Therefore, elucidating the risk factors for cellulitis in patients that have undergone breast cancer treatment is crucial. This is a retrospective medical record study among 523 patients who had received breast cancer treatment and were referred to the Lymphedema Clinic. Data on age, height, weight, BMI (body mass index), education level, arm dominance, history of previous surgery, axillary lymph node dissection, radiotherapy, and chemotherapy were noted. The time between operation and onset of lymphedema, duration of lymphedema, history of cellulitis, and number of cellulitis attacks were recorded. Circumference measurements were taken at four points on the upper limb. Univariate analysis showed that longer duration of lymphedema, larger circumference of the unaffected arm and larger circumference of the arm with lymphedema were associated with higher risk of cellulitis (p=0.008, p=0.007, p< 0.001, respectively). The incidence of cellulitis was higher in patients with lymphedema than patients who had no lymphedema (p< 0.001). Moreover, the frequency of cellulitis was higher in patients with lower education level (p=0.015). It was deter-mined that patients with cellulitis needed more compression garments (p< 0.001) and multi-layered bandage therapy (p< 0.001) than those without. Regression analysis revealed that presence of lymphedema (p=0.036), duration of lymphedema (p=0.048), radiotherapy (p=0.01) and educational level (0.019) are significantly associated with developing upper extremity cellulitis. It is important to consider these risk factors for the prevention and management of cellulitis in patients who undergo treatment for breast cancer. Early detection and treatment of lymphedema also remains essential for these patients.

Identifiants

pubmed: 36170582

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-83

Informations de copyright

Copyright by International Society of Lymphology.

Déclaration de conflit d'intérêts

The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.

Auteurs

O Engin (O)

Department of Physical Medicine and Rehabilitation, Izmir Democracy University, Izmir, Turkey.

E Sahin (E)

Department of Physical Medicine and Rehabilitation, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey.

E Saribay (E)

Department of Econometrics, Faculty of Economics and Administrative Sciences, Dokuz Eylül University, İzmir, Turkey.

B Dilek (B)

Department of Physical Medicine and Rehabilitation, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey.

E Akalin (E)

Department of Physical Medicine and Rehabilitation, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH